Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA interference for antiviral therapy.

Mali Ketzinel-Gilad1, Yosef Shaul, Eithan Galun

  • 1Goldyne Savad Institute of Gene Therapy, Hadassah Hebrew University Hospital, Jerusalem, Israel.

The Journal of Gene Medicine
|June 17, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disruption of the brain-spleen axis impairs monocyte-microglia communication and accelerates disease progression in a mouse model of amyloidosis.

Nature communications·2026
Same author

A Systematic Review and Meta-Analysis on the Impact of Military Foot Marches on Performance-Part 2: Cognitive Performance.

Journal of strength and conditioning research·2026
Same author

A Systematic Review and Meta-Analysis on the Impact of Military Foot Marches on Performance-Part 1: Physical Performance.

Journal of strength and conditioning research·2026
Same author

Hepatic radiofrequency ablation induces widespread cellular activation throughout the liver.

European radiology experimental·2026
Same author

Empowering exhausted T cells of Glioblastoma patients by Neurotransmitters and Neuropeptides: decreasing immune checkpoint inhibitors, and increasing CD3zeta, proliferation and Glioblastoma arrest.

Cancer immunology, immunotherapy : CII·2026
Same author

Human primary skeletal muscle cells express glutamate receptor GluR3, are activated by glutamate, and are affected by autoimmune GluR3B antibodies of epilepsy patients.

Frontiers in physiology·2025
Same journal

Identification and Experimental Verification of Key Genes Related to the Ras Signaling Pathway and the Hippo Signaling Pathway in Osteoarthritis Based on Transcriptome Data.

The journal of gene medicine·2026
Same journal

ZNF468 Exhibits Oncogenic Activity by Regulating Unexplored ZNF707 in Breast Cancer.

The journal of gene medicine·2026
Same journal

The Histidine-Rich Glycoprotein A1043G Polymorphism and Susceptibility to Recurrent Miscarriage in Erbil-The Kurdistan Region of Iraq.

The journal of gene medicine·2026
Same journal

In Vivo Assessment of dbDNA GNE<sup>wt</sup>/bi-shRNA-GNE<sup>M743T</sup> Lipoplex for GNE Myopathy: Improved Potency and Safety.

The journal of gene medicine·2026
Same journal

F2R Promotes Prostate Cancer Progression via COL8A1-Dependent Activation of the FAK/PI3K/AKT Signaling Axis.

The journal of gene medicine·2026
Same journal

Rational Design and Optimisation of CRISPR-Cas9 Delivery Systems for Targeted Genomic Transformation.

The journal of gene medicine·2026
See all related articles

RNA interference (RNAi) silences gene expression and shows promise for treating viral infections. Overcoming delivery challenges is key to developing RNAi therapeutics for human diseases.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • RNA interference (RNAi) is a natural gene silencing mechanism observed in plants.
  • RNAi plays a role in innate immunity against viral pathogens.
  • Viral pathogens have evolved mechanisms to counteract RNAi.

Purpose of the Study:

  • To explore the potential of RNA interference (RNAi) as a therapeutic strategy against human viral infections.
  • To review the current understanding of RNAi-mediated gene silencing for therapeutic applications.
  • To identify key challenges and future directions for RNAi-based therapies.

Main Methods:

  • Utilizing specifically designed double-stranded RNA (dsRNA) molecules to induce RNA interference.
  • Investigating RNAi efficacy in both acute and chronic human viral infections.

Related Experiment Videos

  • Evaluating RNAi in in vitro and in vivo models.

    • Main Results:

    • RNAi can effectively silence gene expression in human viral pathogens.
    • Demonstrated potential for RNAi in treating viral infections in experimental models.
    • Identified significant hurdles including specificity, longevity, and dsRNA delivery.

    Conclusions:

    • RNAi holds promise as a gene-specific therapeutic approach for viral diseases.
    • Successful translation of RNAi into therapeutics hinges on resolving delivery and control issues.
    • Further research is needed to overcome obstacles for clinical application of RNAi.